BR0108096A - Método para manter ou melhorar a sìntese de mucinas - Google Patents

Método para manter ou melhorar a sìntese de mucinas

Info

Publication number
BR0108096A
BR0108096A BR0108096-2A BR0108096A BR0108096A BR 0108096 A BR0108096 A BR 0108096A BR 0108096 A BR0108096 A BR 0108096A BR 0108096 A BR0108096 A BR 0108096A
Authority
BR
Brazil
Prior art keywords
maintaining
improving
synthesis
mucin
disease states
Prior art date
Application number
BR0108096-2A
Other languages
English (en)
Other versions
BRPI0108096B1 (pt
Inventor
Olivier Ballevre
Paul-Andre Finot
Denis Breuille
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27052980&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0108096(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US09/774,814 external-priority patent/US6833350B2/en
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of BR0108096A publication Critical patent/BR0108096A/pt
Publication of BRPI0108096B1 publication Critical patent/BRPI0108096B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

"MéTODO PARA MANTER OU MELHORAR A SìNTESE DE MUCINAS". Métodos para manter, melhorar ou aumentar a síntese de mucina administrando-se um suplemento ou composição nutricional que contém uma quantidade terapeuticamente eficaz de treonina são fornecidos. A presente invenção ainda fornece métodos para tratar diversos estados de doença caracterizados pelas alterações dos níveis de mucina, tal como, infecções bacterianas e inflamatórias intestinais ou outros tipos de estados de doença.
BRPI0108096A 2000-02-04 2001-01-31 usos de uma fonte de proteína compreendendo aminoácidos em que o teor de treonina é de pelo menos 5,5% em peso dos aminoácidos BRPI0108096B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US49890500A 2000-02-04 2000-02-04
US09/774,814 US6833350B2 (en) 2000-02-04 2001-01-30 Method for maintaining or improving the synthesis of mucins
PCT/EP2001/001013 WO2001056405A2 (en) 2000-02-04 2001-01-31 A method for maintaining or improving the synthesis of mucins

Publications (2)

Publication Number Publication Date
BR0108096A true BR0108096A (pt) 2002-10-29
BRPI0108096B1 BRPI0108096B1 (pt) 2017-05-09

Family

ID=27052980

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0108096A BRPI0108096B1 (pt) 2000-02-04 2001-01-31 usos de uma fonte de proteína compreendendo aminoácidos em que o teor de treonina é de pelo menos 5,5% em peso dos aminoácidos

Country Status (22)

Country Link
EP (1) EP1255452B2 (pt)
JP (1) JP2003533436A (pt)
CN (1) CN1434681B (pt)
AT (1) ATE323422T1 (pt)
AU (1) AU784137B2 (pt)
BG (1) BG106967A (pt)
BR (1) BRPI0108096B1 (pt)
CA (1) CA2399063C (pt)
CZ (1) CZ20022978A3 (pt)
DE (1) DE60118888T3 (pt)
DZ (1) DZ3298A1 (pt)
ES (1) ES2261383T5 (pt)
HR (1) HRP20020647A2 (pt)
HU (1) HUP0204439A3 (pt)
IL (1) IL150977A (pt)
MA (1) MA25656A1 (pt)
MX (1) MXPA02007491A (pt)
NO (1) NO20023640L (pt)
NZ (1) NZ520605A (pt)
PL (1) PL357078A1 (pt)
SK (1) SK11212002A3 (pt)
WO (1) WO2001056405A2 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2382874A1 (en) 2003-06-23 2011-11-02 Nestec S.A. Amino acid supplementation for a healthy microbiota ecosystem
JPWO2007004613A1 (ja) * 2005-07-01 2009-01-29 味の素株式会社 炎症性腸疾患治療薬及びＴＮＦ−α産生抑制剤
CN101365350A (zh) * 2006-01-09 2009-02-11 雀巢技术公司 应激患者的治疗
WO2012133198A1 (ja) * 2011-03-25 2012-10-04 イーエヌ大塚製薬株式会社 炎症性疾患用栄養組成物
EP2734210B1 (en) 2011-07-22 2017-11-22 Abbott Laboratories Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
EP3167895A1 (en) * 2015-11-10 2017-05-17 University College Dublin A dietary supplement comprising beta-glucan and casein hydrolysate for improving health and growth performance in a mammal

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2459620B1 (fr) * 1979-06-26 1983-08-05 Agronomique Inst Nat Rech Hydrolisat enzymatique total de proteines de lactoserum, obtention et application
US5162373A (en) * 1986-01-17 1992-11-10 Board Of Regents, The University Of Texas System Methods and improved formulations for the determination and treatment of malignant disease in patients
JP2631470B2 (ja) * 1987-05-15 1997-07-16 雪印乳業株式会社 感染防御剤
CA1338682C (en) * 1988-12-23 1996-10-29 Gustavo Bounous Biologically active undenatured whey protein concentrate as food supplement
JP2805490B2 (ja) * 1989-02-07 1998-09-30 雪印乳業株式会社 細菌毒素中和剤
JP3007694B2 (ja) * 1990-12-14 2000-02-07 雪印乳業株式会社 胃潰瘍予防または治療のための医薬及び飲食品
CA2143420C (en) * 1992-12-23 1999-01-19 Phyllis J. B. Acosta Medical foods for the nutritional support of infant/toddler metabolic diseases
NZ248605A (en) * 1993-05-28 1994-12-22 Abbott Lab Enteral nutritional product comprising protein and fat
FR2711529B1 (fr) * 1993-10-28 1996-07-05 Clintec Nutrition Cy Composition à base d'acides aminés destinée au traitement d'une infection ou d'une agression engendrant une réaction inflammatoire, chez les animaux et chez l'homme.
JPH07267855A (ja) * 1994-03-30 1995-10-17 Taiho Yakuhin Kogyo Kk グルタミン産生剤
US5952314A (en) * 1994-04-01 1999-09-14 Demichele; Stephen Joseph Nutritional product for a person having ulcerative colitis
US5728678A (en) * 1995-06-06 1998-03-17 Nestec Ltd. Method and composition for providing nutrition to a renal failure patient
US5670157A (en) * 1995-12-11 1997-09-23 Nestec Ltd. Method for reducing and controlling immunoglobulin concentrations
US5922766A (en) * 1997-07-02 1999-07-13 Acosta; Phyllis J. B. Palatable elemental medical food
CA2300076A1 (en) * 1997-09-16 1999-03-25 Societe Des Produits Nestle S.A. Organ specific nutrition
CA2331921A1 (en) * 1998-06-24 1999-12-29 Boyce Thompson Institute For Plant Research, Inc. A novel invertebrate intestinal mucin cdna and related products and methods
EP1034704A1 (en) * 1999-03-12 2000-09-13 Societe Des Produits Nestle S.A. Nutritional composition intended for specific gastro-intestinal maturation in premature mammals
JP2003512839A (ja) * 1999-10-22 2003-04-08 ザ ボード オブ リージェンツ オブ ザ ユニバーシティ オブ ネブラスカ 初乳由来の血清アミロイドａアイソフォーム

Also Published As

Publication number Publication date
HUP0204439A3 (en) 2004-12-28
EP1255452B2 (en) 2010-03-03
DE60118888T2 (de) 2007-01-18
CN1434681A (zh) 2003-08-06
ES2261383T5 (es) 2010-06-18
DE60118888T3 (de) 2010-09-23
PL357078A1 (en) 2004-07-12
NO20023640D0 (no) 2002-07-31
CA2399063A1 (en) 2001-08-09
MA25656A1 (fr) 2002-12-31
DE60118888D1 (de) 2006-05-24
IL150977A0 (en) 2003-02-12
JP2003533436A (ja) 2003-11-11
HUP0204439A2 (hu) 2003-04-28
AU4056401A (en) 2001-08-14
ATE323422T1 (de) 2006-05-15
EP1255452B1 (en) 2006-04-19
CA2399063C (en) 2014-01-28
MXPA02007491A (es) 2002-12-13
BG106967A (bg) 2003-04-30
CZ20022978A3 (cs) 2003-02-12
CN1434681B (zh) 2010-12-08
ES2261383T3 (es) 2010-06-14
EP1255452A2 (en) 2002-11-13
HRP20020647A2 (en) 2004-12-31
IL150977A (en) 2005-09-25
BRPI0108096B1 (pt) 2017-05-09
NO20023640L (no) 2002-09-19
WO2001056405A3 (en) 2002-01-24
WO2001056405A2 (en) 2001-08-09
AU784137B2 (en) 2006-02-09
SK11212002A3 (sk) 2003-01-09
DZ3298A1 (fr) 2001-08-09
NZ520605A (en) 2004-06-25

Similar Documents

Publication Publication Date Title
TW200503708A (en) Gyrase inhibitors and uses thereof
ES2096262T3 (es) Nuevas cyclosporins modificadas en la posicion 1.
PT721449E (pt) Inibidores da producao da proteina beta-amiloide
BR0208142A (pt) Combinações compreendendo um agente antidiarréico e epotilona ou derivado de epotilona
DE602004021644D1 (de) Gyraseinhibitoren und deren verwendungen
MY138708A (en) Biaryloxymethylarenecarboxylic acids
EA200100623A1 (ru) Кетолидные антибиотики
BRPI0406883A (pt) Composto, composição farmacêutica, método de tratar um distúrbio, e, uso de um composto
BR0015698A (pt) Composições e métodos para tratamento de doenças alérgicas
BRPI0510761A (pt) métodos de tratar um paciente afligido com pelo menos uma enfermidade e de reduzir ou eliminar rugas
IL172773A (en) Formulations for the treatment of arthritis conditions
BRPI0408882A (pt) composições contendo lactulose para tratamento de infecções por rotavìrus
WO2004011477A3 (en) 6,11-4-carbon bridged ketolides
BRPI0409609A (pt) mediadores do transporte reverso de colesterol para o tratamento da hipercolesterolemia
BR9712141A (pt) Aplicação de 1-hifróxi-2-piridonas para tratamento de infecções cutâneas.
BR0209128A (pt) Compostos, composições farmacêuticas, métodos para o tratamento de dores, métodos para a modulação de uma resposta farmacológica e usos de compostos
BRPI0413404A (pt) composições farmacêuticas, métodos de tratamento ou prevenção de disfunções cardìacas, métodos de aumento da função cardìaca e método de identificação de inibidor de mif
BR9911917A (pt) Composições compreendendo análogos de gaba e cafeìna
BRPI0406477A (pt) Composição, agente de tratamento de óleo, e, métodos de produção de uma composição e de tratamento de óleo
ATE516027T1 (de) Orazamid orotat zur vorbeugung von leberschäden
ES2096988T3 (es) Organopolisiloxanos que contienen grupos hidrofilos.
ATE554753T1 (de) 2,2'-dithio-bis(ethansulfonat) für den einsatz zur hemmung paclitaxel-induzierter abnormer thermoesthesia
BRPI0414139A (pt) métodos e composições para tratar infecções por herpes
BR0309406A (pt) Composição farmacêutica, processo de preparação, kit e métodos para tratamento de obesidade, utilização de composição e inibidor de lìpases, inibidor de lìpáses e glucomanan ou konjac e utilização dos mesmos e método de tratamento
MX2020010425A (es) Composicion isotopicamente modificada y sus usos terapeuticos.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O ART .8O COMBINADO COM ART. 13 DA LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A23L 33/12 (2016.01)